Back

State of the Art lecture: Prolonged DAPT – when, in whom, how long?

3 March 2019 (17:10 - 17:30)
Organised by:
Congress Presentation Part of: Prolonged DAPT after acute coronary syndrome: individualise! Treatment ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

4 More presentations in this session

Presentation thumbnail
This programme is supported by AstraZeneca in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Slides
Presentation thumbnail
Prolonged DAPT after acute coronary syndrome: individualise! - Panel
Presentation thumbnail
Case 1: A patient with a low DAPT score and an interventionist with a gut feeling.
Doctor A. Mischie (Montlucon, FR)
Slides Video
Presentation thumbnail
Case 2: The dilemma: a patient with both a high bleeding and thrombotic risk.
Doctor N. Morici (Milan, IT)
Slides Video

Access the full session

Session thumbnail
Prolonged DAPT after acute coronary syndrome: individualise!

The Event

Event poster

Acute Cardiovascular Care 2019

3 March 2019 17:10 CET
You may be interested in
thumbnail
Congress Presentation
When should we prolong DAPT beyond 12 months?
1 September 2024
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Congress Presentation
Statin and DAPT use for post-ACS patients during covid-19 pandemic: changing perspectives of Indian practitioners
29 June 2021
thumbnail
Congress Presentation
New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources